• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

VLA蛋白家族。五种不同细胞表面异二聚体的特性,每种异二聚体都有一个共同的分子量为130,000的β亚基。

The VLA protein family. Characterization of five distinct cell surface heterodimers each with a common 130,000 molecular weight beta subunit.

作者信息

Hemler M E, Huang C, Schwarz L

出版信息

J Biol Chem. 1987 Mar 5;262(7):3300-9.

PMID:3546305
Abstract

The family of human cell surface heterodimers which includes VLA-1 and VLA-2 is now shown to include three additional heterodimers, here called VLA-3, VLA-4, and VLA-5. Each of these separate VLA structures is composed of a distinct alpha subunit (Mr 110,000-200,000 nonreduced) noncovalently associated with a common beta subunit (Mr 110,000 nonreduced). Chemical cross-linking experiments provided evidence that each VLA complex exists predominantly as a 1:1 alpha beta heterodimer. The VLA proteins are widely distributed, with one or more of the heterodimers present on nearly all cell types tested. Evidence for five distinct VLA alpha subunits was obtained from differences observed in antibody recognition, cell distribution patterns, two-dimensional gel analyses, and V8 protease cleavage patterns. On the other hand, the beta subunit present in each heterodimer was immunochemically and electrophoretically indistinguishable, and yielded identical V8 cleavage fragments. Immunoblotting experiments revealed that besides the Mr 110,000 beta normally seen, another beta protein was present that is smaller in size (Mr 90,000 nonreduced), altered or deficient in glycosylation, and not available for cell surface radiolabeling.

摘要

包括VLA - 1和VLA - 2在内的人类细胞表面异二聚体家族,现已发现还包括另外三种异二聚体,这里称为VLA - 3、VLA - 4和VLA - 5。这些各自独立的VLA结构均由一个独特的α亚基(非还原状态下Mr为110,000 - 200,000)与一个共同的β亚基(非还原状态下Mr为110,000)非共价结合而成。化学交联实验提供了证据,表明每个VLA复合物主要以1:1的αβ异二聚体形式存在。VLA蛋白广泛分布,在几乎所有测试的细胞类型上都存在一种或多种异二聚体。从抗体识别、细胞分布模式、二维凝胶分析以及V8蛋白酶切割模式中观察到的差异,获得了存在五种不同VLAα亚基的证据。另一方面,每个异二聚体中存在的β亚基在免疫化学和电泳方面无法区分,并且产生相同的V8切割片段。免疫印迹实验显示,除了通常可见的Mr为110,000的β蛋白外,还存在另一种β蛋白,其大小较小(非还原状态下Mr为90,000),糖基化改变或缺乏,并且不能用于细胞表面放射性标记。

相似文献

1
The VLA protein family. Characterization of five distinct cell surface heterodimers each with a common 130,000 molecular weight beta subunit.VLA蛋白家族。五种不同细胞表面异二聚体的特性,每种异二聚体都有一个共同的分子量为130,000的β亚基。
J Biol Chem. 1987 Mar 5;262(7):3300-9.
2
Biochemical characterization of VLA-1 and VLA-2. Cell surface heterodimers on activated T cells.VLA - 1和VLA - 2的生化特性。活化T细胞上的细胞表面异二聚体。
J Biol Chem. 1985 Dec 5;260(28):15246-52.
3
Characterization of the cell surface heterodimer VLA-4 and related peptides.细胞表面异二聚体VLA - 4及相关肽的表征
J Biol Chem. 1987 Aug 25;262(24):11478-85.
4
Multiple very late antigen (VLA) heterodimers on platelets. Evidence for distinct VLA-2, VLA-5 (fibronectin receptor), and VLA-6 structures.血小板上的多种极晚期抗原(VLA)异二聚体。VLA - 2、VLA - 5(纤连蛋白受体)和VLA - 6独特结构的证据。
J Biol Chem. 1988 Jun 5;263(16):7660-5.
5
Platelet glycoproteins Ia, Ic, and IIa are physicochemically indistinguishable from the very late activation antigens adhesion-related proteins of lymphocytes and other cell types.血小板糖蛋白Ia、Ic和IIa在物理化学性质上与淋巴细胞及其他细胞类型的极晚期活化抗原黏附相关蛋白无法区分。
J Clin Invest. 1988 Feb;81(2):505-13. doi: 10.1172/JCI113348.
6
Association of the VLA alpha 6 subunit with a novel protein. A possible alternative to the common VLA beta 1 subunit on certain cell lines.VLAα6亚基与一种新蛋白质的关联。在某些细胞系上可能是常见VLAβ1亚基的替代物。
J Biol Chem. 1989 Apr 15;264(11):6529-35.
7
Use of the monoclonal antibody 12F1 to characterize the differentiation antigen VLA-2.
J Immunol. 1987 Jan 1;138(1):226-33.
8
Identification of specific human epithelial cell integrin receptors as VLA proteins.将特定人类上皮细胞整合素受体鉴定为VLA蛋白。
Exp Cell Res. 1990 Apr;187(2):277-83. doi: 10.1016/0014-4827(90)90092-o.
9
Fibronectin receptor structures in the VLA family of heterodimers.异二聚体VLA家族中的纤连蛋白受体结构
Nature. 1987;326(6113):607-9. doi: 10.1038/326607a0.
10
Integrin molecules involved in lymphocyte homing to Peyer's patches.参与淋巴细胞归巢至派尔集合淋巴结的整合素分子。
Immunol Rev. 1989 Apr;108:45-61. doi: 10.1111/j.1600-065x.1989.tb00012.x.

引用本文的文献

1
Novel Ligands Targeting αβ Integrin: Therapeutic Applications and Perspectives.靶向αβ整合素的新型配体:治疗应用与展望
Front Chem. 2019 Jul 9;7:489. doi: 10.3389/fchem.2019.00489. eCollection 2019.
2
The integrin-binding defective FGF2 mutants potently suppress FGF2 signalling and angiogenesis.整合素结合缺陷型FGF2突变体可有效抑制FGF2信号传导和血管生成。
Biosci Rep. 2017 Apr 10;37(2). doi: 10.1042/BSR20170173. Print 2017 Apr 28.
3
Aspergillus fumigatus CalA binds to integrin αβ and mediates host cell invasion.烟曲霉 CalA 与整合素 αβ 结合并介导宿主细胞侵袭。
Nat Microbiol. 2016 Nov 14;2:16211. doi: 10.1038/nmicrobiol.2016.211.
4
Extracellular matrix stiffness causes systematic variations in proliferation and chemosensitivity in myeloid leukemias.细胞外基质硬度导致髓系白血病在增殖和化疗敏感性方面出现系统性差异。
Proc Natl Acad Sci U S A. 2016 Oct 25;113(43):12126-12131. doi: 10.1073/pnas.1611338113. Epub 2016 Oct 10.
5
Integrin-based therapeutics: biological basis, clinical use and new drugs.基于整合素的疗法:生物学基础、临床应用与新药
Nat Rev Drug Discov. 2016 Mar;15(3):173-83. doi: 10.1038/nrd.2015.10. Epub 2016 Jan 29.
6
Kindlin-3 interacts with the ribosome and regulates c-Myc expression required for proliferation of chronic myeloid leukemia cells.Kindlin-3与核糖体相互作用,并调节慢性粒细胞白血病细胞增殖所需的c-Myc表达。
Sci Rep. 2015 Dec 18;5:18491. doi: 10.1038/srep18491.
7
Pathogenicity of Bovine Neonatal Pancytopenia-associated vaccine-induced alloantibodies correlates with Major Histocompatibility Complex class I expression.牛新生全血细胞减少症相关疫苗诱导的同种异体抗体的致病性与主要组织相容性复合体I类表达相关。
Sci Rep. 2015 Aug 3;5:12748. doi: 10.1038/srep12748.
8
Association between polymorphisms in the integrin gene predicted microRNA binding sites and bladder cancer risk.整合素基因预测的微小RNA结合位点多态性与膀胱癌风险之间的关联。
Int J Clin Exp Med. 2014 Nov 15;7(11):4398-405. eCollection 2014.
9
A Golgi-localized pool of the mitotic checkpoint component Mad1 controls integrin secretion and cell migration.有丝分裂检查点组件Mad1的高尔基体定位池控制整合素分泌和细胞迁移。
Curr Biol. 2014 Nov 17;24(22):2687-92. doi: 10.1016/j.cub.2014.09.052. Epub 2014 Oct 23.
10
Hypoxia-induced changes to integrin α 3 glycosylation facilitate invasion in epidermoid carcinoma cell line A431.缺氧诱导的整合素α3糖基化变化促进表皮样癌细胞系A431的侵袭。
Mol Cell Proteomics. 2014 Nov;13(11):3126-37. doi: 10.1074/mcp.M114.038505. Epub 2014 Jul 30.